As GLP-1 Pills Near FDA Approval, Bryant Expert Emphasizes Lifestyle Changes to Manage Side Effects of Drugs for Weight Loss
October 11, 2025
October 11, 2025
SMITHFIELD, Rhode Island, Oct. 11 -- Bryant University issued the following news:
* * *
As GLP-1 pills near FDA approval, Bryant expert emphasizes lifestyle changes to manage side effects of drugs for weight loss
By Emma Bartlett
Move over GLP-1 injectables; Novo Nordisk -- creator of Ozempic and Wegovy -- and Eli Lilly -- producer of Zepbound -- are racing to develop a pill version of their drugs to help people shed pounds.
" . . .
* * *
As GLP-1 pills near FDA approval, Bryant expert emphasizes lifestyle changes to manage side effects of drugs for weight loss
By Emma Bartlett
Move over GLP-1 injectables; Novo Nordisk -- creator of Ozempic and Wegovy -- and Eli Lilly -- producer of Zepbound -- are racing to develop a pill version of their drugs to help people shed pounds.
" . . .